Khaled Abdelrahman

Dr. Khaled Abdelrahman holds BSc (Pharmaceutical Sciences) and MSc (Pharmacology) from Alexandria University. He received his PhD in 2015 from the University Calgary where he studied the molecular basis underlying altered cerebrovascular function in type 2 diabetes. He then joined the Departments of Cellular & Molecular Medicine and Neuroscience at the University of Ottawa to explore novel G protein-coupled receptor candidates that can be targeted pharmacologically to slow the progression of Alzheimer’s and Huntington’s diseases. His research was supported by prestigious salary awards offered by Canadian Institutes for Health Research and Alberta Innovates. He is also the recipient of the Canadian Society of Pharmacology and Therapeutics Postdoctoral award and many young investigator awards from the American Society for Pharmacology and Experimental Therapeutics. He is a Registered Pharmacist with over 12 years of clinical expertise in providing patient care. He is currently an Assistant Professor in the Department of Anesthesiology, Pharmacology and Therapeutics in the Faculty of Medicine at the University of British Columbia.